Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

VAMP-3 Inhibitors

The class of chemicals identified as VAMP-3 inhibitors comprises a diverse range of compounds primarily known for their ability to modulate key cellular processes such as vesicular transport, cytoskeletal dynamics, and membrane fusion. These inhibitors do not directly target VAMP-3 but influence the cellular environment and signaling networks that regulate VAMP-3's activity or expression. The primary mechanism of action for these inhibitors involves the alteration of cellular structures and pathways crucial for vesicular transport and fusion, where VAMP-3 plays a role. Compounds like Brefeldin A, Nocodazole, Monensin, and Cytochalasin D target different aspects of cellular transport machinery, such as the Golgi apparatus, microtubules, and actin filaments. By modulating these structures, these inhibitors can indirectly impact VAMP-3's function in vesicle trafficking and membrane fusion. Disruption of microtubule and actin dynamics, for instance, can lead to impaired vesicle movement and positioning, affecting VAMP-3-mediated processes.

Another aspect of VAMP-3 inhibition by these compounds is their impact on protein processing and cellular signaling. Agents like Tunicamycin, which inhibits N-linked glycosylation, and Wortmannin, a PI3K inhibitor, can indirectly inhibit VAMP-3 by altering protein trafficking and cellular signaling pathways. Additionally, compounds like Okadaic Acid, which affects protein phosphorylation, can influence phosphorylation-dependent processes involved in vesicular transport and membrane fusion. The effectiveness of these compounds in specifically inhibiting VAMP-3 depends on various factors, including the specific cellular context, concentration, and duration of exposure. It's important to consider the broader cellular effects of these compounds, as they influence a wide range of cellular processes and pathways. While these compounds offer insights into the regulation of VAMP-3 activity, their role in specifically targeting VAMP-3-mediated processes warrants further experimental validation in relevant biological models.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A disrupts the Golgi apparatus, affecting vesicular transport. It might indirectly inhibit VAMP-3 by altering the vesicle trafficking process, a key aspect of VAMP-3's function.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Nocodazole disrupts microtubules, impacting cellular transport mechanisms. Its effect on microtubule dynamics can indirectly inhibit VAMP-3 activity by affecting vesicle transport and positioning.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Monensin, an ionophore that disrupts lysosomal function, can indirectly inhibit VAMP-3 by affecting intracellular trafficking and vesicle fusion processes, where VAMP-3 is involved.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Cytochalasin D inhibits actin polymerization, impacting cell shape and transport. Its effect on the cytoskeleton can indirectly inhibit VAMP-3 by disrupting vesicle movement and fusion.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore inhibits dynamin, a protein involved in vesicle scission. By inhibiting dynamin, Dynasore might indirectly inhibit VAMP-3 by disrupting the vesicle formation and trafficking process.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Latrunculin A disrupts actin filaments, affecting cytoskeletal dynamics. Its influence on actin can indirectly inhibit VAMP-3 by altering vesicle movement and membrane fusion events.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, affecting protein folding and trafficking. This can indirectly inhibit VAMP-3 by disrupting the proper processing and transport of membrane proteins.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$100.00
$321.00
$2289.00
$4484.00
$18207.00
$34749.00
3
(2)

Colchicine binds to tubulin, disrupting microtubules. Its effect on microtubule dynamics can indirectly inhibit VAMP-3 by affecting vesicular transport pathways.

Vinblastine

865-21-4sc-491749
sc-491749A
sc-491749B
sc-491749C
sc-491749D
10 mg
50 mg
100 mg
500 mg
1 g
$102.00
$235.00
$459.00
$1749.00
$2958.00
4
(0)

Vinblastine, a microtubule inhibitor, can indirectly inhibit VAMP-3 by disrupting microtubule-dependent vesicle transport, impacting VAMP-3's role in vesicle fusion.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$61.00
$110.00
21
(1)

Chlorpromazine, an antipsychotic drug, can disrupt clathrin-mediated endocytosis. This disruption might indirectly inhibit VAMP-3 by affecting the vesicle formation and recycling process.